Silexion Therapeutics Ltd. (SLXN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.55M |
| Enterprise Value | -2.97M |
| P/E Ratio | 0.05 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.01 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.07 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.81 |
| Return On Equity | -5.17 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -11.88M |
| Net Income | -11.91M |
| Diluted EPS | -89.6 |
| Total Cash | 2.41M |
| Total Cash/Share | 7.47 |
| Total Debt | 436,000 |
| Total Debt/Equity | 1.5 |
| Current Ratio | 1 |
| Book Value Per Share | 0.9 |
| 52-Week Change | -97.79 |
| 52-Week High | 223.6 |
| 52-Week Low | 2.31 |
| Moving Average 50 Days | 5.78 |
| Moving Average 200 Days | 20.9 |
| Average Volume | 628,384 |
| Shares Outstanding | 418,995 |
| % Held by Institutions | 1.13 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | May 29, 2026 |